SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080201768> ?p ?o ?g. }

Showing items 1 to 78 of 78 with 100 items per page.

W2080201768 endingPage "12" @default.
W2080201768 startingPage "7" @default.
W2080201768 abstract "Vinorelbine (Navelbine) is a new, semisynthetic 5'Nor-vinca-alkaloid, modified on the catharantine ring, developed by Pierre Fabre Médicament. Vinorelbine is a potent as the other vinca alkaloids to inhibit mitotic microtubule polymerization. On the other hand, its activity is lower on axonal microtubule. Preclinical studies have shown its broad spectrum of activity in vitro and its antitumoral efficacy comparable or higher to that of other vinca alkaloids against murine tumors and in xenograft models. The main experimental toxicity of vinorelbine is a reversible leucopenia. No neurotoxicity was evidenced in rats, dogs and monkeys. After i.v. injection in patients, the plasma kinetic is described by a tricompartimental model with a high clearance, a very large volume of distribution and a long terminal half life, intermediate between vincristine and vinblastine. Tissue uptake of vinorelbine is very intense, probably related to its high liposolubility, leading to high tissue concentration compared to plasma. Phase I trial using weekly i.v. administration demonstrated a maximal tolerated dose (MTD) of 27.5 to 35.4 mg/m2 and the recommended dose was established at 30 mg/m2 weekly. In Phase II studies, Vinorelbine was shown to be effective in at least 4 types of cancer: Non-small cell lung cancer (remission rate: 33%), breast cancer (45%), advanced ovarian cancer (15% in heavily pretreated patients), Hodgkin's disease (90%). In all the trials, side effects are generally limited to a reversible and non-cumulative leucopenia. Neurotoxicity appears to be mild, similar to that observed with vinblastine and much less severe than with vincristine. No evidence of cardiac, pulmonary, renal, hepatic or other organ system toxicity has emerged.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
W2080201768 created "2016-06-24" @default.
W2080201768 creator A5017584347 @default.
W2080201768 creator A5026198041 @default.
W2080201768 date "1991-01-01" @default.
W2080201768 modified "2023-10-14" @default.
W2080201768 title "Vinorelbine (Navelbine®). A New Semisynthetic Vinca Alkaloid" @default.
W2080201768 doi "https://doi.org/10.1159/000216938" @default.
W2080201768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2057177" @default.
W2080201768 hasPublicationYear "1991" @default.
W2080201768 type Work @default.
W2080201768 sameAs 2080201768 @default.
W2080201768 citedByCount "24" @default.
W2080201768 countsByYear W20802017682014 @default.
W2080201768 countsByYear W20802017682020 @default.
W2080201768 crossrefType "journal-article" @default.
W2080201768 hasAuthorship W2080201768A5017584347 @default.
W2080201768 hasAuthorship W2080201768A5026198041 @default.
W2080201768 hasConcept C112705442 @default.
W2080201768 hasConcept C121608353 @default.
W2080201768 hasConcept C126322002 @default.
W2080201768 hasConcept C185592680 @default.
W2080201768 hasConcept C2776553716 @default.
W2080201768 hasConcept C2776694085 @default.
W2080201768 hasConcept C2776755627 @default.
W2080201768 hasConcept C2777096885 @default.
W2080201768 hasConcept C2777132456 @default.
W2080201768 hasConcept C2777292972 @default.
W2080201768 hasConcept C2777667214 @default.
W2080201768 hasConcept C2778239845 @default.
W2080201768 hasConcept C2779429289 @default.
W2080201768 hasConcept C2779491297 @default.
W2080201768 hasConcept C2780350996 @default.
W2080201768 hasConcept C29730261 @default.
W2080201768 hasConcept C71240020 @default.
W2080201768 hasConcept C71924100 @default.
W2080201768 hasConcept C98274493 @default.
W2080201768 hasConceptScore W2080201768C112705442 @default.
W2080201768 hasConceptScore W2080201768C121608353 @default.
W2080201768 hasConceptScore W2080201768C126322002 @default.
W2080201768 hasConceptScore W2080201768C185592680 @default.
W2080201768 hasConceptScore W2080201768C2776553716 @default.
W2080201768 hasConceptScore W2080201768C2776694085 @default.
W2080201768 hasConceptScore W2080201768C2776755627 @default.
W2080201768 hasConceptScore W2080201768C2777096885 @default.
W2080201768 hasConceptScore W2080201768C2777132456 @default.
W2080201768 hasConceptScore W2080201768C2777292972 @default.
W2080201768 hasConceptScore W2080201768C2777667214 @default.
W2080201768 hasConceptScore W2080201768C2778239845 @default.
W2080201768 hasConceptScore W2080201768C2779429289 @default.
W2080201768 hasConceptScore W2080201768C2779491297 @default.
W2080201768 hasConceptScore W2080201768C2780350996 @default.
W2080201768 hasConceptScore W2080201768C29730261 @default.
W2080201768 hasConceptScore W2080201768C71240020 @default.
W2080201768 hasConceptScore W2080201768C71924100 @default.
W2080201768 hasConceptScore W2080201768C98274493 @default.
W2080201768 hasIssue "1" @default.
W2080201768 hasLocation W20802017681 @default.
W2080201768 hasLocation W20802017682 @default.
W2080201768 hasOpenAccess W2080201768 @default.
W2080201768 hasPrimaryLocation W20802017681 @default.
W2080201768 hasRelatedWork W1977329570 @default.
W2080201768 hasRelatedWork W2019956090 @default.
W2080201768 hasRelatedWork W2080201768 @default.
W2080201768 hasRelatedWork W2155176893 @default.
W2080201768 hasRelatedWork W2337038517 @default.
W2080201768 hasRelatedWork W2362403869 @default.
W2080201768 hasRelatedWork W2372474964 @default.
W2080201768 hasRelatedWork W2413848477 @default.
W2080201768 hasRelatedWork W322740912 @default.
W2080201768 hasRelatedWork W4233601073 @default.
W2080201768 hasVolume "14" @default.
W2080201768 isParatext "false" @default.
W2080201768 isRetracted "false" @default.
W2080201768 magId "2080201768" @default.
W2080201768 workType "article" @default.